Format
Items per page

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Heart failure

MedGen UID:
6749
Concept ID:
C0018801
Disease or Syndrome
2.

Heart Failure

MedGen UID:
880986
Concept ID:
CN236639
Disease or Syndrome
3.

Pressure

MedGen UID:
632176
Concept ID:
C0460139
Finding
4.

Pulmonary artery pressure

Blood pressure in the pulmonary artery. [from NCI]

MedGen UID:
606580
Concept ID:
C0428642
Finding
5.

Congestive heart failure

MedGen UID:
9169
Concept ID:
C0018802
Disease or Syndrome
6.

Ventricular Dysfunction

Impairment of the ventricle to either fill or eject adequately. [from NCI]

MedGen UID:
69305
Concept ID:
C0242973
Pathologic Function
7.

Hypertension

MedGen UID:
6969
Concept ID:
C0020538
Disease or Syndrome
8.

Error occurred: cannot get document summary

ID:
1462882

9.

Hypertension

MedGen UID:
635666
Concept ID:
C0497247
Finding
10.

Left

Being located on the left side of the body. [from HPO]

MedGen UID:
618170
Concept ID:
C0443246
Spatial Concept
11.

Pulmonary arterial hypertension

MedGen UID:
468368
Concept ID:
C3203102
Disease or Syndrome
12.

Pulmonary alveolar proteinosis acquired

Pulmonary alveolar proteinosis is a pathologic entity characterized by intraalveolar surfactant accumulation. There are 3 clinically distinct forms: hereditary (usually congenital), secondary, and acquired. The acquired form of pulmonary alveolar proteinosis is the most common form, accounting for approximately 90% of cases. The mean age at diagnosis is 39 years and it is associated with smoking in 72% of cases. The estimated incidence and prevalence are 0.36 and 3.70 cases per million, respectively (Trapnell et al., 2003; Seymour and Presneill, 2002). Secondary pulmonary alveolar proteinosis develops in association with conditions involving functional impairment or reduced numbers of alveolar macrophages. Such conditions include some hematologic cancers, pharmacologic immunosuppression, inhalation of inorganic dust or toxic fumes, and certain infections. Congenital pulmonary alveolar proteinosis is a rare, severe, often fatal disorder of newborns associated with pulmonary surfactant metabolism dysfunction caused by mutations in genes involved in surfactant metabolism (see, e.g., SMDP1, 265120) (Trapnell et al., 2003). See 300770 for information on congenital PAP due to CSF2RA (306250) deficiency. [from OMIM]

MedGen UID:
410079
Concept ID:
C1970472
Disease or Syndrome
13.

Pituitary adenoma predisposition

MedGen UID:
354959
Concept ID:
C1863340
Finding
14.

Left Ventricular Dysfunction

Impairment of the left ventricle to either fill or eject adequately. [from NCI]

MedGen UID:
69237
Concept ID:
C0242698
Pathologic Function
15.

Pulmonary alveolar proteinosis

MedGen UID:
18760
Concept ID:
C0034050
Disease or Syndrome
16.

Pulmonary hypertension

Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. [from MeSH]

MedGen UID:
9376
Concept ID:
C0020542
Finding; Pathologic Function
17.

Diseases, Respiratory Tract

Diseases involving the RESPIRATORY SYSTEM. [from MeSH]

MedGen UID:
19750
Concept ID:
C0035242
Disease or Syndrome
18.

UPREG

A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. [from MeSH]

MedGen UID:
12003
Concept ID:
C0041904
Molecular Function
19.

Disorder of lung

MedGen UID:
7399
Concept ID:
C0024115
Disease or Syndrome
20.

Heart disease

MedGen UID:
5458
Concept ID:
C0018799
Disease or Syndrome
Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center